Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing
Abstract Much of the therapeutic potential of mesenchymal stromal cells (MSCs) is underpinned by their secretome which varies significantly with source, donor and microenvironmental cues. Understanding these differences is essential to define the mechanisms of MSC-based tissue repair and optimise ce...
Saved in:
Main Authors: | Margeaux Hodgson-Garms, Matthew J. Moore, Mikaël M. Martino, Kilian Kelly, Jessica E. Frith |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Regenerative Medicine |
Online Access: | https://doi.org/10.1038/s41536-024-00382-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
by: Rosaria Santoro, et al.
Published: (2019-01-01) -
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01) -
Phenotypic alterations in articulating joint cells: Role of mechanically loaded MSC secretome
by: Yann D. Ladner, et al.
Published: (2025-02-01) -
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
by: Rubén Fernández-Santiago, et al.
Published: (2016-01-01) -
Multitasking muscle: engineering iPSC-derived myogenic progenitors to do more
by: Mark Stephen Hamer, et al.
Published: (2025-01-01)